Massive haemoptysis is rare but associated with a high mortality. Even in a major regional cardiothoracic centre only one or two cases will be seen annually. As a consequence, no consensus about its investigation and management has emerged, with the result that much time may be lost on inappropriate investigation and treatment may be misdirected.